All articles by Amit Thadani
First approval of TAAV synthetic DNA material for use in clinical trial
Synthetic DNA material to be used in upcoming approved Huntington’s disease study in France may be key to scaling gene therapy production
Refurbished Medical Imaging Equipment Market to Grow at 9.1% CAGR during Forecast Period: TMR Study
WILMINGTON, Del., — In 2021, the global refurbished medical imaging equipment market size was worth US$ 7.1 Bn. The global market is likely to progress at 9.1% CAGR during the forecast period, from 2022 to 2031. By 2031, the global refurbished medical imaging equipment market is anticipated to touch value of US$ 18.3 Bn. Due to the rising need for imaging devices for the diagnosis of numerous illnesses, the global market for refurbished medical imaging equipment is anticipated to expand quickly in the coming years. With the exception of a few illnesses, medical imaging technology including MRI, X-ray, and CT scan scanners is widely utilized to identify practically every problem.
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
T-Cell Select reagent kit simplifies the T-SPOT.TB test laboratory workflow through automation expanding access to the most sensitive latent TB test on the market
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
IMT-009 Phase 1/2a clinical trial initiation expected in Q4 2022
Stryker receives FDA clearance for OptaBlate Bone Tumor Ablation System
Stryker’s first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
— CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells
International elite of sports medicine meets for the 10th MEDICA MEDICINE + SPORTS MEDICINE in Düsseldorf
Focus on innovative procedures and technologies for professional and health sports
HHS Technology Group, Datavant, and Mathematica Partner to Combat Chronic Kidney Disease
The nation’s largest COVID-19 Research Database and advanced data-analysis platform to power the early identification of patients at risk of developing chronic kidney disease
Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022
On November 15th, World Cord Blood Day 2022 celebrations will be held around the globe (free online medical conference and educational events worldwide – open to the public). Learn how cord blood is used to treat 80+ life-threatening diseases including many blood cancers and holds tremendous potential in the treatment of HIV, autism and cerebral palsy.
Tabula Rasa HealthCare Announces Leadership Transition
Drs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman